GlassScriptPhysician profile
Adam J Grunbaum
NPI 1255522488
$16,617.06
in general payments reported to CMS, 2019-2025
36 companies · $2,788 in 2025
The $2,788 reported for 2025 was more than what 75% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,800 · 2020: $2,368 · 2021: $2,355 · 2022: $1,659 · 2023: $2,196 · 2024: $2,451 · 2025: $2,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,416 · Education: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,415.57 |
| Education | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,271.68 | 2019-2025 | Enbrel, Evenity, Otezla |
| Abbvie INC. | $2,637.89 | 2019-2025 | |
| Ucb, INC. | $1,290.33 | 2019-2025 | Cimzia, Bimzelx |
| Pfizer INC. | $1,034.22 | 2019-2025 | |
| Genzyme Corporation | $1,027.59 | 2019-2025 | |
| Horizon Therapeutics Plc | $803.53 | 2019-2023 | Krystexxa |
| Glaxosmithkline, LLC. | $744.93 | 2019-2025 | Benlysta |
| Janssen Biotech, INC. | $669.62 | 2019-2025 | Tremfya, Simponi, Stelara |
| Novartis Pharmaceuticals Corporation | $632.84 | 2019-2025 | |
| Lilly USA, LLC | $585.21 | 2019-2025 | Taltz |
| Sobi, INC | $560.78 | 2019-2025 | |
| Radius Health, INC. | $426.81 | 2019-2025 | Tymlos |
| Mallinckrodt Hospital Products INC. | $415.78 | 2021-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $386.82 | 2021-2025 | Saphnelo |
| Fresenius Kabi USA, LLC | $311.41 | 2023-2025 | Idacio, Tyenne |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Grunbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.